Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
Context: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition. Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD. Design: The design was a randomized, double-blind, parallel-group, placebo-controlled, 24-wk study (the Intimate SM 1 study). Setting: The study was performed at private or institutional practices. Patients: The subjects studied were women, aged 26–70 yr, with HSDD after bilateral salpingo-oophorectomy who were receiving concomitant estrogen therapy. Placebo (n = 279) or testosterone 300 μg/d (n = 283) was administered. There were 19 patients who withdrew due to adverse events in the placebo group and 24 in the 300 μg/d testosterone group. Intervention: Testosterone (300 μg/d) or placebo patches were applied twice weekly. Main Outcome Measure(s): The primary end point was the change in the frequency of total satisfying sexual activity at 24 wk. Secondary end points included other sexual functioning end points and safety assessments. Results: At 24 wk, there was an increase from baseline in the frequency of total satisfying sexual activity of 2.10 episodes/4 wk in the testosterone group, which was significantly greater than the change of 0.98 episodes/4 wk in the placebo group (P = 0.0003). The testosterone group also experienced statistically significant improvements in sexual desire and a decrease in distress. The overall safety profile was similar in both treatment groups. Conclusion: In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another androgen (testosterone) also improves sexual function in surgically menopausal women (55,56).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [56]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954 · cited 1×
“01 300 g/d 271 7 [0, 14] 143 19 [9, 36] Androstenedione [50–250 ng/dl] Placebo 276 58 [32, 108] 157 52 [21, 87] 0.”
Self-citationSherwin, B. B., Gelfand, M. M., & Brender, W. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00004 · Cited by 547 · cited 1×
“5] Total testosterone [12–50 ng/dl] Placebo 279 17 [8, 28] 219 16 [7, 28] 0.”
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394
Basson, R., McInnes, R., Smith, M. D., Hodgson, G., & Koppiker, N. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902317586001 · Cited by 289
HORMONAL DYNAMICS ASSOCIATED WITH THE MENOPAUSE
Judd, H. L. (1976) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-197612000-00005 · Cited by 158
LORENZO, E. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-31-5-556 · Cited by 131
Psychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
Nathorst-Böös, J., & von Schoultz, B. (1992) · Gynecologic and Obstetric Investigation · doi:10.1159/000292735 · Cited by 126
DEROGATIS, L., RUST, J., GOLOMBOK, S., BOUCHARD, C., NACHTIGALL, L., RODENBERG, C., KUZNICKI, J., & MCHORNEY, C. A. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490247183 · Cited by 121
Self-citationSexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis
ZUSSMAN, L., Zussman, S., Sunley, R., & Bjornson, E. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90730-4 · Cited by 103
Cited by
ESHRE Guideline: management of women with premature ovarian insufficiency
(2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,555
“Womenshouldbe informed that androgen treatment isonlysupported by limited data, and that long-term health effects are not clear yet (Shifren et al., 2000; Braunstein et al., 2005; Buster et al., 2005; Simon et al., 2005; Davis et al., 2006, 2008; Tamimi et al., 2006; Panay et al., 2010) C”
BackgroundPsychological and Interpersonal Dimensions of Sexual Function and Dysfunction
McCabe, M., Althof, S. E., Assalian, P., Chevret-Measson, M., Leiblum, S. R., Simonelli, C., & Wylie, K. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01618.x · Cited by 598
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G. D., Hirschberg, A. L., Rodenberg, C., Pack, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707302 · Cited by 479
“Except for a higher incidence of hair growth reported by women assigned to testosterone in the present study, the incidence of androgenic adverse events was similar to that observed in prior studies of similar duration.(11-16) The increased hair growth observed during the study was not significantly related to higher…”
InfluentialSelf-citationEstrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
Morrison, J. H., Brinton, R. D., Schmidt, P. J., & Gore, A. C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3369-06.2006 · Cited by 386
“Several recent RCTs reported improvements in libido after testosterone therapy in hypogonadal women (Shifren et al., 2000; Simon et al., 2005).”
BackgroundThe Relationship Between Self-Reported Sexual Satisfaction and General Well-Being in Women
Davison, S. L., Bell, R. J., LaChina, M., Holden, S. L., & Davis, S. R. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01406.x · Cited by 375
Self-citationAndrogen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
“In two large studies (n 562, n 532) of TTP, 300 g/d, in surgically menopausal women on oral estrogen therapy, the number of satisfying sexual events improved from three times to five times per month with active therapy and four times a month with placebo (117, 180), ie, a statistically significant median increase of o…”
Self-citationA Mindfulness-Based Group Psychoeducational Intervention Targeting Sexual Arousal Disorder in Women
Brotto, L. A., Basson, R., & Luria, M. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00850.x · Cited by 355
Sexual dysfunction in men and women with endocrine disorders
Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60280-3 · Cited by 319
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Self-citationShifren, J. L., Davis, S. R., Moreau, M., Waldbaum, A., Bouchard, C., DeRogatis, L., Derzko, C., Bearnson, P., Kakos, N., O'Neill, S., et al. (2006) · Menopause · doi:10.1097/01.gme.0000243567.32828.99 · Cited by 300
“5 (24, 266) 205 83 (20, 264) 184 80 (22, 245) Testosterone 269 85 (20, 252) 214 77.”
Self-citationde Villiers, T. J., Pines, A., Panay, N., Gambacciani, M., Archer, D. F., Baber, R. J., Davis, S. R., Gompel, A. A., Henderson, V. W., Langer, R., et al. (2013) · Climacteric · doi:10.3109/13697137.2013.795683 · Cited by 298
Self-citationSexual sequelae of general medical disorders
Basson, R., & Weijmar Schultz, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60197-4 · Cited by 283
Islam, R. M., Bell, R. J., Green, S., Page, M. J., & Davis, S. R. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30189-5 · Cited by 278
Self-citationTestosterone for peri and postmenopausal women
Somboonporn, W., Bell, R. J., & Davis, S. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004509.pub2 · Cited by 241
Self-citationHypoactive Sexual Desire Disorder
Goldstein, I., Kim, N. N., Clayton, A. H., DeRogatis, L. R., Giraldi, A., Parish, S. J., Pfaus, J., Simon, J. A., Kingsberg, S. A., Meston, C., et al. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.09.018 · Cited by 230
“In double-blind, placebo-controlled clinical trials in naturally and surgically menopausal women, testosterone therapy resulted in statistically significant improvements in the number of satisfying sexual events, sexual desire, and sexual distress that were 2-fold greater than placebo.(44,79) The short-term safety of…”
BackgroundSelf-citationClayton, A. H., Goldstein, I., Kim, N. N., Althof, S. E., Faubion, S. S., Faught, B. M., Parish, S. J., Simon, J. A., Vignozzi, L., Christiansen, K., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.002 · Cited by 226
“Likewise, long-term (beyond 2 years) safety data with regard to breast cancer and cardiovascular events are limited to observational trials and are inconclusive.(171,176,179,180) Studies involving reproductive-aged women are lacking.”
BackgroundSelf-citationCornil, C. A., Ball, G. F., & Balthazart, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.098 · Cited by 223
Miller, K. K., Biller, B. M. K., Beauregard, C., Lipman, J. G., Jones, J., Schoenfeld, D., Sherman, J. C., Swearingen, B., Loeffler, J., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2596 · Cited by 225
Finch, A., Metcalfe, K. A., Chiang, J. K., Elit, L., McLaughlin, J., Springate, C., Demsky, R., Murphy, J., Rosen, B., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.12.326 · Cited by 200
“Testosterone therapy has shown to improve sexual functioning [18,31,34,35].”
BackgroundLabrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e85c6 · Cited by 191
“The median range age of women was 58 (49-70), 57 (42-72), 58 (50-74), and 59 (46-69) years in the four groups.”
Self-citationLong-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
“Another androgen (testosterone) also improves sexual function in surgically menopausal women (55, 56).”
BackgroundSexual Desire and Arousal Disorders in Women
Basson, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050154 · Cited by 189
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Solomon, Z. J., Mirabal, J. R., Mazur, D. J., Kohn, T. P., Lipshultz, L. I., & Pastuszak, A. W. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.09.006 · Cited by 174
“[31] For example, treatment with testosterone patches in women with hypoactive sexual desire disorder after bilateral salpingo-oophorectomy increased episodes of satisfying sexual encounters and increased sexual desire.[32]”
Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens
Cappelletti, M., & Wallen, K. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.11.003 · Cited by 169
“Ten out of twelve studies found that supraphysiological testosterone enhanced the effectiveness of an estrogen therapy at increasing sexual desire in postmenopausal women (Burger et al., 1987; Flöter et al., 2002; Sherwin et al., 1985; Sherwin & Gelfand, 1987; Braunstein et al., 2005; Buster et al., 2005; Davis et al.…”
BackgroundMethodInfluentialTestosterone treatment of HSDD in naturally menopausal women: the ADORE study
Panay, N., Al-Azzawi, F., Bouchard, C., Davis, S. R., Eden, J., Lodhi, I., Rees, M., Rodenberg, C. A., Rymer, J., Schwenkhagen, A., et al. (2010) · Climacteric · doi:10.3109/13697131003675922 · Cited by 169
Self-citation(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003324 · Cited by 160
The association of testosterone, sleep, and sexual function in men and women
Andersen, M. L., Alvarenga, T. A., Mazaro‐Costa, R., Hachul, H., & Tufik, S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.060 · Cited by 179
“Randomized controlled trials demonstrate the efficacy of TT in correcting sexual desire disorders in postmenopausal women (Hubayter and Simon, 2008; Simon et al., 2005).”
BackgroundWitherby, S., Johnson, J., Demers, L., Mount, S., Littenberg, B., Maclean, C. D., Wood, M., & Muss, H. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0435 · Cited by 156
Simon, J. A., Kingsberg, S. A., Shumel, B. S., Hanes, V., Garcia, M., & Sand, M. S. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000134 · Cited by 166
Self-citationIs There a Correlation Between Androgens and Sexual Desire in Women?
Wåhlin-Jacobsen, S., Pedersen, A. T., Kristensen, E., Læssøe, N. C., Lundqvist, M., Cohen, A. S., Hougaard, D. M., & Giraldi, A. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12774 · Cited by 151
Parish, S. J., Simon, J. A., Davis, S. R., Giraldi, A. G. E., Goldstein, I., Goldstein, S. W., Kim, N. N., Kingsberg, S. A., Morgentaler, A., Nappi, R. E., et al. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.10.009 · Cited by 182
“This population was included in RCTs of testosterone therapy in postmenopausal women aged 24e70 years.(11,12,136) Results demonstrated improvement in sexual function including desire; however, age analyses were not performed.”
MethodSelf-citationSexual Function in Chronic Kidney Disease
Anantharaman, P., & Schmidt, R. J. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2007.01.002 · Cited by 152
Achilli, C., Pundir, J., Ramanathan, P., Sabatini, L., Hamoda, H., & Panay, N. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.028 · Cited by 148
Original Research: Prevalence and Evaluation of Sexual Health Problems—HSDD in Europe
Graziottin, A. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00447.x · Cited by 169
Perrone, A. M., Cerpolini, S., Maria Salfi, N. C., Ceccarelli, C., De Giorgi, L. B., Formelli, G., Casadio, P., Ghi, T., Pelusi, G., Pelusi, C., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01380.x · Cited by 142
Simon, J. A., Goldstein, I., Kim, N. N., Davis, S. R., Kellogg‐Spadt, S., Löwenstein, L., Pinkerton, J. V., Stuenkel, C. A., Traish, A. M., Archer, D. F., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001138 · Cited by 143
Self-citationHypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of Life and Health Burden
Biddle, A. K., West, S. L., D’Aloisio, A. A., Wheeler, S. B., Borisov, N. N., & Thorp, J. M. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00483.x · Cited by 155
HRT for women with premature ovarian insufficiency: a comprehensive review
Webber, L., Anderson, R. A., Davies, M., Janse, F., & Vermeulen, N. (2017) · Human Reproduction Open · doi:10.1093/hropen/hox007 · Cited by 141
“Androgenic side effects (acne, hirsutism, deepening of the voice and androgenic alopecia) are rare with doses below 300 μg of testosterone per day (Buster et al., 2005; Simon et al., 2005).”
BackgroundArlt, W. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02062 · Cited by 131
“(A) Serum androstenedione (A’dione), total testosterone (T) and dihydrotestosterone (DHT) (all medians, 10th-90th percentile) after 24 weeks of treatment with transdermal testosterone at a dose of 300mg/day in surgically menopausal women (n ¼ 283) compared with placebo treatment (n ¼ 279), as reported by Simon et al.…”
InfluentialDavis, S. R., Worsley, R., Miller, K. K., Parish, S. J., & Santoro, N. F. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.033 · Cited by 128
Self-citationFemale Sexual Dysfunction—Medical and Psychological Treatments, Committee 14
Kingsberg, S. A., Althof, S., Simon, J. A., Bradford, A., Bitzer, J., Carvalho, J., Flynn, K. E., Nappi, R. E., Reese, J. B., Rezaee, R. L., et al. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.05.018 · Cited by 125
Self-citationEndocrine Aspects of Women’s Sexual Function
Wierman, M. E., Nappi, R. E., Avis, N., Davis, S. R., Labrie, F., Rosner, W., & Shifren, J. L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01629.x · Cited by 123
Self-citationKingsberg, S. A., Clayton, A. H., & Pfaus, J. G. (2015) · CNS Drugs · doi:10.1007/s40263-015-0288-1 · Cited by 134
Nijland, E. A., Schultz, W. C. M. W., Nathorst‐Böös, J., Helmond, F. A., van Lunsen, R. H. W., Palacios, S., Norman, R. J., Mulder, R. J., Davis, S. R., & Lisa study investigators (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00726.x · Cited by 127
Self-citationDavis, S. R., & Braunstein, G. D. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02634.x · Cited by 120
Self-citationEastwick, P. W. (2009) · Psychological Bulletin · doi:10.1037/a0016845 · Cited by 116
“Indeed, testosterone supplements are often effective at both alleviating erectile dysfunction in men (Jain, Rademaker, & Mcvary, 2000) and increasing sexual desire in women (Simon et al., 2005).”
BackgroundThe Women's Health Initiative trial and related studies: 10 years later: A clinician's view
Gurney, E. P., Nachtigall, M. J., Nachtigall, L. E., & Naftolin, F. N. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.009 · Cited by 133
Self-citationTorréns, J. I., Sutton-Tyrrell, K., Zhao, X., Matthews, K. A., Brockwell, S. E., Sowers, M. R., & Santoro, N. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318185e249 · Cited by 130
“for women, and at lower doses of T, carbohydrate metabolism has been reported to be unaffected in two short-term studies of more than 1,000 women, although specific measures were not shown and long-term data are not available.(34,35) We have previously demonstrated that high FAI and low SHBG levels were strongly and c…”
BackgroundAslan, E., & Fynes, M. M. (2007) · International Urogynecology Journal · doi:10.1007/s00192-007-0436-3 · Cited by 139
Huang, G., Basaria, S., Travison, T. G., Ho, M. H., Davda, M., Mazer, N. A., Miciek, R., Knapp, P. E., Zhang, A., Collins, L., et al. (2014) · Menopause · doi:10.1097/gme.0000000000000093 · Cited by 119
“3) Sex hormoneYbinding globulin, nmol/L 64 (23) 73 (35) 59 (24) 64 (36) 92 (39) Hematocrit, % 39 (3) 39 (2) 38 (3) 39 (3) 40 (2) Total cholesterol, mg/dL 195 (29) 215 (46) 218 (40) 198 (33) 199 (48) Low-density lipoprotein, mg/dL 113 (23) 119 (47) 108 (29) 118 (28) 104 (32) High-density lipoprotein, mg/dL 57 (16) 64 (…”
Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause
Birkhäuser, M. H., Birkhäuser, M. H., Panay, N., Archer, D. F., Barlow, D., Burger, H., Gambacciani, M., Goldstein, S., Pinkerton, J. A., & Sturdee, D. W. (2008) · Climacteric · doi:10.1080/13697130801983921 · Cited by 112
Barton, D. L., Wender, D. B., Sloan, J. A., Dalton, R. J., Balcueva, E. P., Atherton, P. J., Bernath, A. M., DeKrey, W. L., Larson, T., Bearden, J. D., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk149 · Cited by 111
Continuing Medical Education: The Use of Estrogen Therapy in Women’s Sexual Functioning (CME)
Nappi, R. E., & Polatti, F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01198.x · Cited by 107
The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI
Nappi, R. E., & Davis, S. R. (2012) · Climacteric · doi:10.3109/13697137.2012.657589 · Cited by 115
Self-citationManaging female sexual dysfunction
Buster, J. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.08.026 · Cited by 104
Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals
Loverro, G., Resta, L., Dellino, M., Naro, E. D., Cascarano, M. A., Loverro, M., & Mastrolia, S. A. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2016.03.004 · Cited by 116
Women's sexual function and dysfunction: current uncertainties, future directions
Basson, R. J. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.23 · Cited by 117
Blaustein, J. D. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093556 · Cited by 101
Surgical menopause: effects on psychological well-being and sexuality
Shifren, J. L., & Avis, N. E. (2007) · Menopause · doi:10.1097/gme.0b013e318032c505 · Cited by 100
Clayton, A. H., Althof, S. E., Kingsberg, S. A., Derogatis, L. R., Kroll, R., Goldstein, I., Kaminetsky, J. C., Spana, C., Lucas, J. D., Jordan, R., et al. (2016) · Women s Health · doi:10.2217/whe-2016-0018 · Cited by 105
Self-citationGonadal dysfunction in chronic kidney disease
Palmer, B. F., & Clegg, D. J. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9385-9 · Cited by 99
“Use of a testosterone patch has been shown effective in surgically menopausal women with hypoactive sexual disorder and deserves further investigation as to its use in uremic women [92].”
BackgroundDiagnosis and treatment of female sexual dysfunction.
Frank, J., Mistretta, P., & Will, J. (2008) · PubMed · Cited by 124
Safety of testosterone treatment in postmenopausal women
Braunstein, G. D. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.118 · Cited by 103
Self-citationRole of androgens in women's sexual dysfunction
Basson, R., Brotto, L. A., Petkau, A. J., & Labrie, F. (2010) · Menopause · doi:10.1097/gme.0b013e3181d59765 · Cited by 97
Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice
Genazzani, A. R., Monteleone, P., Giannini, A., & Simoncini, T. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab026 · Cited by 131
The many faces of testosterone
Bain, J. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1417 · Cited by 113
“Many post-menopausal or oopho-rectomized women are symptomatic as a consequence of reduced testosterone, the leading symptom being loss of libido (Sherwin and Gelfand 1987; Simon et al 2005).”
Hypoactive sexual desire disorder in postmenopausal women
Nappi, R. E., Wawra, K., & Schmitt, S. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600762265 · Cited by 95
Labrie, F., Derogatis, L., Archer, D. F., Koltun, W., Vachon, A., Young, D., Frenette, L., Portman, D., Montesino, M., Côté, I., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.13045 · Cited by 89
The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
Handelsman, D. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2569 · Cited by 90
A Practitioner's Toolkit for Managing the Menopause
Jane, F., & Davis, S. R. (2014) · Climacteric · doi:10.3109/13697137.2014.929651 · Cited by 97
Self-citationThe varied nature of women's sexuality: Unresolved issues and a theoretical approach
Bancroft, J., & Graham, C. A. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.01.005 · Cited by 106
“Since this study, there have been four further studies in this area, though using a parallel group rather than a cross-over design, and these have reported similar results (Braunstein et al., 2005; Buster et al., 2005; Davis et al., 2006; Simon et al., 2005).”
Both, S., Lew‐Starowicz, M., Luria, M., Sartorius, G. A., Maseroli, E., Tripodi, F. M., Löwenstein, L., Nappi, R. E., Corona, G., Reisman, Y., et al. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.08.005 · Cited by 110
Kingsberg, S. A., Shifren, J. L., Wekselman, K., Rodenberg, C. A., Koochaki, P. E., & Derogatis, L. R. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00526.x · Cited by 91
Self-citationNachtigall, L. E., Casson, P. R., Lucas, J. D., Schofield, V., Melson, C., & Simon, J. A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487597 · Cited by 93
“Serum total testosterone, bioavailable testosterone, free testosterone, dihydrotestosterone (DHT) and sexual hormone binding globulin (SHBG) levels have been measured for 3 years using validated bioanalytical methods [6].”
BackgroundMethodInfluentialSelf-citationAndrogen in postmenopausal women
Yasui, T., Matsui, S., Tani, A., Kunimi, K., Yamamoto, S., & Irahara, M. (2012) · The Journal of Medical Investigation · doi:10.2152/jmi.59.12 · Cited by 91
“It has been reported that transdermal testosterone at a dose of 300 μg/day was effective for sexual desire in surgically and naturally menopausal women (64) and in women with hypoactive sexual desire disorder after surgically induced menopause (65, 66) without any relevant side effects.”
BackgroundBaldassarre, M., Giannone, F. A., Foschini, M. P., Battaglia, C., Busacchi, P., Venturoli, S., & Meriggiola, M. C. (2013) · International Journal of Impotence Research · doi:10.1038/ijir.2013.9 · Cited by 98
Evaluation and Management of Hypoactive Sexual Desire Disorder
Clayton, A. H., Kingsberg, S. A., & Goldstein, I. (2018) · Sexual Medicine · doi:10.1016/j.esxm.2018.01.004 · Cited by 96
Testosterone Reference Ranges in Normally Cycling Healthy Premenopausal Women
Braunstein, G. D., Reitz, R. E., Buch, A., Schnell, D., & Caulfield, M. P. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02380.x · Cited by 101
Self-citationHypoactive sexual desire in women
Kingsberg, S. A., & Rezaee, R. L. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000131 · Cited by 96
Meston, C. M., & Bradford, A. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091507 · Cited by 82
Hormonal Changes in Menopause and Implications on Sexual Health
Schwenkhagen, A. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00448.x · Cited by 89
Testosterone Treatment for Hypoactive Sexual Desire Disorder in Postmenopausal Women
Kingsberg, S. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00449.x · Cited by 79
The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.
Hui, L., Leung, K., & Chen, H. M. (2002) · PubMed · Cited by 95
Krapf, J. M., & Simon, J. A. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.04.008 · Cited by 79
Self-citationAdvances in pharmacotherapy for treating female sexual dysfunction
Nappi, R. E., & Cucinella, L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1020791 · Cited by 79
“Based on the available pivotal Phase III trials [93,94], European regulators approved TTP in 2004 limiting the prescription of TTP to surgically (bilateral ovariectomy plus hysterectomy) menopausal women with HSDD.”
BackgroundTherapeutic options for postmenopausal female sexual dysfunction
Al‐Azzawi, F., Bitzer, J., Brandenburg, U., Castelo‐Branco, C., Graziottin, A., Kenemans, P., Lachowsky, M., Mimoun, S., Nappi, R. E., Palacios, S., et al. (2009) · Climacteric · doi:10.3109/13697130903437615 · Cited by 77
Salonia, A., Pontillo, M., Nappi, R. E., Zanni, G., Fabbri, F., Scavini, M., Daverio, R., Gallina, A., Rigatti, P., Bosi, E., et al. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00791.x · Cited by 73
Testosterone, SHBG and cardiovascular health in postmenopausal women
Brand, J. S., & van der Schouw, Y. T. (2010) · International Journal of Impotence Research · doi:10.1038/ijir.2009.64 · Cited by 82
Poels, S., Bloemers, J., van Rooij, K., Goldstein, I., Gerritsen, J., van Ham, D., van Mameren, F., Chivers, M. L., Everaerd, W. T. A. M., Koppeschaar, H. P. F., et al. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02983.x · Cited by 76
Identifying and Treating Sexual Dysfunction in Postmenopausal Women: The Role of Estrogen
Simon, J. A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2151 · Cited by 81
Self-citationAndrogens, health and sexuality in women and men
Wylie, K. R., REES, M. C. P., Hackett, G. I., Anderson, R. A., Bouloux, P.-M. G., Cust, M., Goldmeier, D., Kell, P. D., TERRY, T. R., TRINICK, T. R., et al. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.07.011 · Cited by 75
“Hirsutism was reported overall in 7% of women receiving estosterone patches, versus 5% for controls, over a period of 4 weeks [68–70].”
BackgroundInfluentialMeskhi, A., & Seif, M. W. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000233937.36554.d3 · Cited by 74
Low-dose Transdermal Testosterone Augmentation Therapy Improves Depression Severity in Women
Miller, K. K., Perlis, R. H., Papakostas, G. I., Mischoulon, D., Iosifescu, D. V., Brick, D. J., & Fava, M. (2009) · CNS Spectrums · doi:10.1017/s1092852900023944 · Cited by 68
El-Hage, G., Eden, J. A., & Zoa Manga, R. (2007) · Climacteric · doi:10.1080/13697130701364644 · Cited by 68
Traish, A. M., Kim, S. W., Stankovic, M. R., Goldstein, I., & Kim, N. N. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00491.x · Cited by 74
White, W. B., Grady, D. G., Giudice, L. C., Berry, S. M., Zborowski, J., & Snabes, M. C. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.09.021 · Cited by 72
Genazzani, A. R., Gambacciani, M., & Simoncini, T. (2007) · Climacteric · doi:10.1080/13697130701297760 · Cited by 82
van Rooij, K., Poels, S., Bloemers, J., Goldstein, I., Gerritsen, J., van Ham, D., van Mameren, F., Chivers, M. L., Everaerd, W. T. A. M., Koppeschaar, H. P. F., et al. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02982.x · Cited by 64
Defreyne, J., Elaut, E., Kreukels, B. P. C., Fisher, A. D., Castellini, G., Staphorsius, A. S., den Heijer, M., Heylens, G., & T'Sjoen, G. G. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.12.020 · Cited by 76
Braunstein, G. D. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00516.x · Cited by 68
Self-citation
Metadata
- Authors
- Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., Rodenberg, C., Lucas, J., & Davis, S.
- Affiliations
- Women’s Health Research Center (J.S.), Laurel, Maryland 20707;
- Cedars-Sinai Medical Center (US)
- New York University (US)
- Rapid Medical Research (US)
- Katz, Kade, and Hewitt, Inc. (M.K.), Cincinnati, Ohio 45219;
- S. A. M. Clinical Research Center (S.M.), San Antonio, Texas 78229;
- Downtown Women's Health Care (US)
- Clinique RSF, Inc. (C.B.), Quebec, Canada G1S 2L6;
- St. Michael's Hospital (CA)
- Procter & Gamble (United States) (US)
- Jean Hailes (AU)
- Corresponding author
- Simon, James
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-09-01
- Volume
- 90
- Issue
- 9
- Pages
- 5226-5233
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041293595
- Semantic Scholar
- 26f1f458c86409345ab57bb45f0ed0c5705b02c2
- Cited by
- 475
- References
- 17
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 15 · 2021: 23 · 2020: 20 · 2019: 13 · 2018: 22 · 2017: 25 · 2016: 18 · 2015: 13 · 2014: 17 · 2013: 19 · 2012: 35
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone patch, hypoactive sexual desire disorder, surgical menopause, sexual desire, sexual activity, sexual dysfunction, salpingo-oophorectomy, estrogen therapy, testosterone replacement therapy, treatment safety
- MeSH terms
- Administration, Cutaneous, Androgens, Double-Blind Method, Female, Humans, Libido, Menopause, Premature, Sexual Behavior, Gynecologic Surgical Procedures, Testosterone, Treatment Outcome, Sexual Dysfunctions, Psychological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.